Akari Therapeutics (AKTX) Stock Chart & Stock Price History → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free AKTX Stock Alerts $1.71 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Akari Therapeutics Stock Price Performance5 Day Performance-5.30%1 Month Performance+16.60%3 Month Performance-24.82%6 Month Performance-46.93%Year-To-Date Performance-45.06%1 Year Performance-47.13% Receive AKTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” AKTX Stock Chart for Sunday, June, 2, 2024 AKTX Chart by TradingView Akari Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.72$1.80+4.96%$1.80$1.7110,798 shs$14.26 million05/30/2024$1.79$1.72-4.19%$1.80$1.639,058 shs$13.58 million05/29/2024$1.81$1.79-1.10%$1.84$1.792,675 shs$14.18 million05/28/2024$1.95$1.81-7.18%$1.95$1.813,714 shs$14.34 million05/27/2024$1.95$1.95$1.95$1.7031,000 shs$15.44 million05/24/2024$1.86$1.95+4.84%$1.95$1.7031,017 shs$15.44 million Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.91$1.86-2.62%$2.35$1.6050,691 shs$14.73 million05/22/2024$1.64$1.91+16.82%$2.04$1.5843,635 shs$15.13 million05/21/2024$1.55$1.64+5.48%$1.68$1.524,398 shs$12.95 million05/20/2024$1.52$1.55+1.97%$1.60$1.5022,630 shs$12.28 million05/17/2024$1.53$1.52-0.65%$1.62$1.4720,155 shs$12.04 million05/16/2024$1.46$1.53+4.79%$1.72$1.446,957 shs$12.12 million05/15/2024$1.46$1.46$1.50$1.466,576 shs$11.56 million05/14/2024$1.49$1.46-2.01%$1.55$1.4116,426 shs$11.57 million05/13/2024$1.60$1.49-6.88%$1.60$1.493,836 shs$11.80 million05/10/2024$1.64$1.60-2.14%$1.65$1.5519,063 shs$12.68 million05/09/2024$1.45$1.64+12.76%$1.75$1.5230,367 shs$12.96 million05/08/2024$1.45$1.45$1.50$1.3211,663 shs$11.48 million05/07/2024$1.34$1.45+8.21%$1.49$1.3512,419 shs$11.48 million05/06/2024$1.36$1.34-1.47%$1.40$1.1716,319 shs$10.61 million05/03/2024$1.47$1.36-7.48%$1.59$1.3320,479 shs$10.77 million05/02/2024$1.70$1.47-13.53%$1.87$1.4338,277 shs$11.64 million05/01/2024$1.54$1.70+10.39%$1.85$1.51162,994 shs$13.46 million04/30/2024$1.28$1.54+20.32%$1.54$1.2939,334 shs$12.20 million04/29/2024$1.19$1.28+8.01%$1.35$1.1822,004 shs$10.14 million04/26/2024$1.19$1.18-0.84%$1.20$1.1710,002 shs$9.35 million04/25/2024$1.19$1.19$1.20$1.173,902 shs$9.43 million04/24/2024$1.22$1.19-2.46%$1.21$1.177,532 shs$9.43 million04/23/2024$1.18$1.22+3.39%$1.24$1.134,786 shs$9.66 million04/22/2024$1.17$1.18+1.18%$1.22$1.1313,919 shs$9.35 million04/19/2024$1.21$1.17-3.62%$1.20$1.083,740 shs$9.24 million04/18/2024$1.19$1.21+1.68%$1.23$1.118,776 shs$9.58 million04/17/2024$1.16$1.19+2.59%$1.21$1.107,932 shs$9.43 million04/16/2024$1.20$1.16-3.33%$1.25$1.1414,524 shs$9.19 million04/15/2024$1.21$1.20-0.83%$1.27$1.209,109 shs$9.51 million04/12/2024$1.18$1.21+2.54%$1.27$1.2128,156 shs$6.84 million04/11/2024$1.30$1.18-9.23%$1.32$1.1237,351 shs$6.67 million04/10/2024$1.30$1.30$1.30$1.1911,273 shs$7.43 million04/09/2024$1.43$1.30-9.09%$1.49$1.307,481 shs$7.35 million04/08/2024$1.41$1.43+1.42%$1.50$1.205,390 shs$8.08 millionThe only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here04/05/2024$1.44$1.43-0.69%$1.52$1.413,798 shs$8.08 million04/04/2024$1.55$1.44-7.10%$1.58$1.4327,921 shs$8.14 million04/03/2024$1.51$1.55+2.65%$1.58$1.5114,093 shs$8.76 million04/02/2024$1.51$1.51$1.56$1.518,244 shs$8.53 million04/01/2024$1.87$1.51-19.03%$1.85$1.50110,540 shs$8.53 million03/29/2024$1.85$1.87+0.81%$1.90$1.7213,382 shs$10.54 million03/28/2024$1.80$1.85+2.78%$1.90$1.7213,382 shs$10.45 million03/27/2024$1.86$1.80-3.23%$1.90$1.7034,767 shs$10.17 million03/26/2024$1.89$1.86-1.59%$1.89$1.8113,901 shs$10.51 million03/25/2024$1.81$1.89+4.42%$1.89$1.872,448 shs$10.68 million03/22/2024$1.83$1.82-0.55%$1.89$1.7459,394 shs$10.28 million03/21/2024$1.90$1.83-3.67%$1.90$1.6629,037 shs$10.34 million03/20/2024$1.91$1.90-0.53%$1.92$1.765,653 shs$10.73 million03/19/2024$2.00$1.91-4.50%$1.98$1.852,721 shs$10.79 million03/18/2024$1.97$2.00+1.52%$2.00$1.971,859 shs$11.30 million03/15/2024$2.04$1.97-3.43%$2.03$1.955,450 shs$11.13 million03/14/2024$2.15$2.04-5.12%$2.16$1.9512,097 shs$11.53 million03/13/2024$2.14$2.15+0.47%$2.20$2.0514,673 shs$12.15 million03/12/2024$2.15$2.14-0.47%$2.29$2.1416,732 shs$12.09 million03/11/2024$2.14$2.15+0.47%$2.17$2.146,415 shs$12.15 million03/08/2024$2.22$2.14-3.60%$2.25$2.117,953 shs$12.09 million03/07/2024$2.20$2.22+0.91%$2.25$2.181,678 shs$12.54 million03/06/2024$2.26$2.20-2.66%$2.37$2.186,035 shs$12.43 million03/05/2024$2.25$2.26+0.45%$2.40$2.2315,034 shs$12.77 million03/04/2024$2.28$2.25-1.32%$2.44$2.2023,574 shs$12.71 million03/01/2024$2.21$2.28+3.17%$2.34$2.219,264 shs$12.88 million Related Companies: Cocrystal Pharma Stock Chart Oncternal Therapeutics Stock Chart Carisma Therapeutics Stock Chart Rockwell Medical Stock Chart AEON Biopharma Stock Chart Anebulo Pharmaceuticals Stock Chart Tharimmune Stock Chart Kezar Life Sciences Stock Chart Equillium Stock Chart Eagle Pharmaceuticals Stock Chart Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKTX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics, Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.